Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended 30Th September, 2018 Considreation Of Buy-Back Of Equity Shares Of The Company And Related Matters

 NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2018 ,inter alia, to consider and approve Approval of the Unaudited Financial Results for the quarter ended 30th September, 2018 Considreation of buy-back of equity shares of the Company and related matters
29-10-2018
Bigul

Fresh triggers kick in for Natco, market share gains for copaxone drug

 Natco Pharma remains as one of the few Indian pharma companies to have medium-term revenue visibility
15-10-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Court Affirms Prior Decisions Finding Copaxone 40 mg/mL Patents Invalid- a milestone for NATCO and its marketing partner Mylan
15-10-2018
Bigul

Shareholding for the Period Ended September 30, 2018

 Natco Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here
11-10-2018
Bigul

Compliance Certificate For The Half Year Ending September 30 2018

 Compliance certificate for the half year ending September 30 2018
10-10-2018
Bigul

Compliance Certificate For The Quarter Ended September 30, 2018

 Compliance Certificate for the quarter ended September 30, 2018
10-10-2018
Bigul

Statement Of Investor Complaints For The Quarter Ended September 2018

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0330 Name of the Signatory :- NATCO Pharma Limited, Adinarayana MDesignation :- Company Secretary and Compliance Officer
05-10-2018
Bigul

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jhansi Tummala
04-10-2018
Bigul

CERTIFICATE UNDER REGULATION 40 (9) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 FOR THE HALF YEAR ENDED 30Th SEPTEMBER 2018

 CERTIFICATE UNDER REGULATION 40 (9) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 FOR THE HALF YEAR ENDED 30th SEPTEMBER 2018
04-10-2018
Bigul

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 Allotment of 140965 equity shares of Rs.2/- each under NATSOP2015
27-09-2018
Next Page
Close

Let's Open Free Demat Account